Globus Medical (GMED) Tops Q2 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Northland Capital Markets Upgrades Globus Medical (GMED) to Outperform
August 6, 2020 7:48 AM EDTNorthland Capital Markets analyst Jason Wittes upgraded Globus Medical (NYSE: GMED) from Market Perform to Outperform with a price target of $65.00.
The analyst commented, "2Q revs of $148.9mm (-23.4%) and EPS of $0.07, easily bested consensus of $99.7mm and ($0.11). Not a complete surprise,... More
